JP Morgan Chase’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285M Buy
6,573,682
+972,951
+17% +$43.5M 0.02% 626
2026
Q1
$262M Buy
5,600,731
+2,589,773
+86% +$121M 0.02% 592
2025
Q4
$146M Buy
3,010,958
+355,564
+13% +$17.6M 0.01% 788
2025
Q3
$125M Buy
2,655,394
+173,463
+7% +$8.37M 0.01% 882
2025
Q2
$120M Buy
2,481,931
+119,100
+5% +$6.09M 0.01% 857
2025
Q1
$131M Buy
2,362,831
+206,556
+10% +$11.2M 0.01% 813
2024
Q4
$104M Sell
2,156,275
-154,534
-7% -$7.86M 0.01% 917
2024
Q3
$133M Buy
2,310,809
+399,301
+21% +$21.6M 0.01% 838
2024
Q2
$92.7M Buy
1,911,508
+123,246
+7% +$5.95M 0.01% 938
2024
Q1
$86.9M Buy
1,788,262
+576,339
+48% +$28.1M 0.01% 1001
2023
Q4
$60.3M Sell
1,211,923
-508,112
-30% -$24.8M 0.01% 1122
2023
Q3
$92.3M Sell
1,720,035
-57,517
-3% -$3.07M 0.01% 843
2023
Q2
$95.8M Sell
1,777,552
-107,193
-6% -$5.77M 0.01% 850
2023
Q1
$103M Sell
1,884,745
-1,591,811
-46% -$77.4M 0.01% 784
2022
Q4
$168M Sell
3,476,556
-41,647
-1% -$1.83M 0.02% 570
2022
Q3
$134M Buy
3,518,203
+2,550,676
+264% +$114M 0.02% 621
2022
Q2
$48.4M Buy
967,527
+915,072
+1,744% +$48.6M 0.01% 1054
2022
Q1
$2.69M Buy
52,455
+3,137
+6% +$162K ﹤0.01% 3521
2021
Q4
$2.47M Sell
49,318
-23,474
-32% -$1.16M ﹤0.01% 3693
2021
Q3
$3.51M Sell
72,792
-58,678
-45% -$2.98M ﹤0.01% 3332
2021
Q2
$6.92M Buy
131,470
+99,231
+308% +$5.18M ﹤0.01% 2756
2021
Q1
$1.59M Sell
32,239
-448,783
-93% -$21.6M ﹤0.01% 3880
2020
Q4
$23.4M Buy
481,022
+245,468
+104% +$12.1M ﹤0.01% 1511
2020
Q3
$11.9M Buy
235,554
+48,543
+26% +$2.5M ﹤0.01% 1910
2020
Q2
$9.55M Sell
187,011
-1,770,981
-90% -$86.1M ﹤0.01% 1936
2020
Q1
$85.6M Buy
1,957,992
+1,877,246
+2,325% +$89.8M 0.02% 623
2019
Q4
$4.05M Buy
80,746
+37,265
+86% +$1.75M ﹤0.01% 2844
2019
Q3
$2.02M Buy
43,481
+10,010
+30% +$432K ﹤0.01% 3412
2019
Q2
$1.44M Sell
33,471
-152,330
-82% -$6.48M ﹤0.01% 3612
2019
Q1
$8.23M Sell
185,801
-10,298
-5% -$441K ﹤0.01% 2220
2018
Q4
$8.51M Buy
196,099
+48,769
+33% +$2.15M ﹤0.01% 2153
2018
Q3
$6.58M Buy
147,330
+114,008
+342% +$4.87M ﹤0.01% 2521
2018
Q2
$1.33M Sell
33,322
-196,848
-86% -$7.75M ﹤0.01% 3662
2018
Q1
$9.23M Buy
230,170
+10,056
+5% +$418K ﹤0.01% 2086
2017
Q4
$9.46M Sell
220,114
-6,546
-3% -$302K ﹤0.01% 2166
2017
Q3
$11.2M Sell
226,660
-38,385
-14% -$1.86M ﹤0.01% 1901
2017
Q2
$12.7M Sell
265,045
-51,022
-16% -$2.44M ﹤0.01% 1791
2017
Q1
$14.3M Buy
316,067
+67,807
+27% +$2.88M ﹤0.01% 1693
2016
Q4
$10M Sell
248,260
-285,992
-54% -$11.3M ﹤0.01% 1912
2016
Q3
$20.4M Sell
534,252
-1,422,102
-73% -$57.1M 0.01% 1356
2016
Q2
$81.9M Sell
1,956,354
-264,177
-12% -$10.8M 0.02% 631
2016
Q1
$89.2M Buy
2,220,531
+272,379
+14% +$10.9M 0.02% 573
2015
Q4
$83.1M Sell
1,948,152
-140,983
-7% -$6.49M 0.02% 614
2015
Q3
$99.2M Buy
2,089,135
+14,957
+0.7% +$762K 0.03% 547
2015
Q2
$103M Buy
2,074,178
+271,958
+15% +$13.8M 0.02% 591
2015
Q1
$89.1M Sell
1,802,220
-50,252
-3% -$2.4M 0.02% 669
2014
Q4
$84.5M Sell
1,852,472
-168,809
-8% -$8.19M 0.02% 706
2014
Q3
$114M Buy
2,021,281
+263,244
+15% +$14.1M 0.03% 573
2014
Q2
$93.5M Buy
1,758,037
+120,292
+7% +$6.38M 0.02% 601
2014
Q1
$85.6M Buy
1,637,745
+109,211
+7% +$5.53M 0.02% 602
2013
Q4
$82M Sell
1,528,534
-140,958
-8% -$7.27M 0.02% 601
2013
Q3
$84.5M Buy
1,669,492
+72,391
+5% +$3.68M 0.03% 595
2013
Q2
$82.3M Buy
+1,597,101
New +$85.1M 0.03% 565

Other funds holding SNY

JP Morgan Chase's SNY Position: Q2 2026 in Review

JP Morgan Chase increased its Sanofi (SNY) stake by 17% in Q2 2026, buying an estimated $43.5M and bringing the position to 6,573,682 shares worth $285M. The position accounts for 0.02% of the portfolio, ranked #626.

JP Morgan Chase first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • JP Morgan Chase held 6,573,682 shares of Sanofi worth $285M as of Q2 2026.
  • JP Morgan Chase bought 972,951 Sanofi shares in Q2 2026, an estimated $43.5M.
  • Sanofi made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #626 holding.
  • JP Morgan Chase first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.